Core Mangement Team
ADOSH MEHTA
ACTING CEO
CHIEF TECHNOLOGY OFFICER
Adosh Mehta serves as Acting CEO and Chief Technology Officer for NCM. Adosh has a background in chemical engineering coupled with over two decades of experience in nano materials research and development. Adosh received his B.Tech in chemical engineering from IIT Kanpur, and then completed his graduate work at Vanderbilt University (Nashville), where he continued to work as a research scientist at the Vanderbilt University Medical Center.
Adosh then moved to Oak Ridge National Laboratory (ORNL). At ORNL he developed unique experimental techniques to study luminescent doped nanoparticles in a joint project with Dr. Ramesh Bhargava. These studies were recognized for their novel contribution to the then new area of doped nanomaterials. He was awarded the Lockheed Martin Significant Achievement Award for the landmark paper on “Rare Earth Luminescence in Y2O3:Eu Nanoparticles”. His work on organic light emitting diodes was featured on the cover of the Journal of Physical Chemistry. Adosh also received the ORNL Laboratory Director’s Research Award in 2002 for his research on conjugated polymer nanorods.
RAMESHWAR N. BHARGAVA
FOUNDER DIRECTOR, CHAIRMAN
& CHIEF SCIENTIST
Rameshwar Bhargava serves as Chairman and Chief Scientist of NCM. He holds a Master’s degree in Physics from the University of Allahabad and a PhD from Columbia University. “Ramesh” has received numerous accolades and honors for his scientific achievements. After working for Bell Labs and IBM, he joined Philips where he rose to the position of Associate Director, Physical Sciences. In that position, his responsibilities included guiding research in Materials Physics, LEDs, Medical & Display Technologies.
Ramesh’s achievements and honors include:
- Fellow of IEEE and American Physical Society.
- Proposed/organized the first Gordon Conf. in 1977 in point and line defects in semiconductors.
- Chairman & Organizer – 3rd International Conference on LEDs, San Francisco, Nov. 1979.
- Chairman of the 6th International Conference on II-VI Compounds, Sept. 1993, Newport, RI.
- Plenary talks at International Luminescence Conference, Beijing, 1987 & International Conference on II-VI Compounds, Okayama, Japan, 1991.
- Wide bandgap II-IV Semiconductors, IEE 17, Editor 1997.
- Doped Nanocrystalline Materials- Physics and Applications R N Bhargava, J. Lum.70 85 1996.
- Optical Properties of Mn Doped Nanocrystals of ZnS, R. N. Bhargava, D. Gallagher, X. Hong, & A. Nurmikko, Phys. Rev. Letters, 72, p. 416, 1994.
- II-IV Compounds, North Holland 1993, Co-Editor.
- Compact Blue Lasers in the Near Future, J. Cryst. Growth, 117, p. 894, 1992.
Overall 90 Publications and 25 Patents issued including the several patents in Nanotechnology such as:
Displays Comprising Doped Nanocrystal Phosphors # 5,455,489
Method of Manufacturing Encapsulated Doped Particles # 5,525,377
Method of Producing Rare-Earth Activated Metal Oxide Nanocrystals # 5,637,258
Composite Nanophosphor Screen for detecting Radiation # 5,952,665
Self Aligning QCA based Nanomaterials #7,175, 778
Quantum Confined Atom (QCA) based Nanomagnets # 7,993,541
RAJAN K. PILLAI
FOUNDER DIRECTOR
PRESIDENT/COO
Rajan K. Pillai is a founder Director and President/COO of NCM. Rajan received an LLM degree from Harvard Law School where he graduated as class valedictorian as well as the LL.B. and M.Sc. degrees in Physics (done concurrently) from Mumbai University. He was also a recipient of a Senior New Nations Fellowship from the University of Chicago Law School. While working as a corporate/securities attorney with major law firms in New York City and as an investment banker in Hong Kong, he was responsible for launching/financing several new ventures. Rajan was also a co-founder of Medi-Rx America, Inc. and Duramed Pharmaceuticals, Inc. both of which had an IPO, and Trinity Laboratories, Inc. which was acquired by Jubilant Life Sciences, Ltd., a publicly traded pharma company in India. During 1993 to 1997, Rajan Pillai was Managing Director of Peregrine Capital Ltd., then Hong Kong’s largest investment bank. During his tenure at Peregrine, he worked on various project finance transactions. As a corporate attorney, he has worked on IPOs, mergers and acquisitions, and project finance assignments such as the Kalimantan Fertilizer project (a $415 M project) and the expansion of the Krakatau steel plant (a $160 M project) in Indonesia.